EIM
BIOA

Essex Investment Management’s BioAmber Inc. BIOA Stock Holding History

Essex Investment Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-98,512
Closed -$542K – 391
2016
Q4 		$542K Sell
98,512
-24,107
-20% -$116K 0.09% 239
2016
Q3 		$520K Buy
122,619
+21,257
+21% +$78.6K 0.08% 248
2016
Q2 		$302K Sell
101,362
-340
-0.3% -$1.24K 0.05% 282
2016
Q1 		$427K Sell
101,702
-21,354
-17% -$89.6K 0.07% 249
2015
Q4 		$760K Buy
123,056
+4,620
+4% +$34.8K 0.12% 188
2015
Q3 		$634K Buy
118,436
+28,965
+32% +$191K 0.1% 199
2015
Q2 		$769K Buy
89,471
+10,791
+14% +$98.7K 0.12% 190
2015
Q1 		$685K Buy
78,680
+19,952
+34% +$175K 0.1% 209
2014
Q4 		$493K Buy
58,728
+21,870
+59% +$199K 0.07% 227
2014
Q3 		$368K Buy
+36,858
New +$431K 0.06% 265

Other funds holding BIOA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Essex Investment Management's BIOA Position: Q1 2017 in Review

Essex Investment Management sold out of BioAmber Inc. (BIOA) in Q1 2017, closing a stake of 98,512 shares — an estimated $542K sold.

Essex Investment Management first reported a position in BIOA in Q3 2014 and held it in 10 quarters. The position peaked at $769K in Q2 2015. 35 funds tracked by Wall St. Rank hold BIOA as of Q1 2017.

  • Essex Investment Management reported no remaining BioAmber Inc. position as of Q1 2017 after selling out during the quarter.
  • Essex Investment Management sold 98,512 BioAmber Inc. shares in Q1 2017, an estimated $542K.
  • Essex Investment Management first reported a position in BioAmber Inc. in Q3 2014 and held it in 10 quarters.
  • Essex Investment Management's BioAmber Inc. position peaked at $769K in Q2 2015.
  • 35 funds tracked by Wall St. Rank held BioAmber Inc. as of Q1 2017.

Based on Essex Investment Management's 13F filing for Q1 2017, filed 27 Apr 2017.